COMPANY

Daxor Corporation

Also known as Daxor · 5 sources

Daxor Corporation is listed on ClinicalTrials.gov as the lead sponsor of 4 studies; the most recently updated is “BVA-200 vs BVA-100 Validation Study” (completed), in Heart Failure, High Blood Pressure, High Cholesterol. Daxor Corporation has received NIH funding, most recently in fiscal 2023 for the project “Precision Guidance of Resuscitation and Deresuscitation in Sepsis”. From public records Source · Oct 12, 2026

Keywords: Heart Failure High Blood Pressure High Cholesterol Anemia Diabetes Thyroid Diseases Kidney Diseases Clotting Disorder Trauma Acute Decompensated Heart Failure Hypoalbuminemia Nephrosis Cirrhosis Shock

Location: Oak Ridge, TN · source · Oct 14, 2026

Profile checked Oct 10, 2026

$9.0MRaised (2 yrs)4Trials (company is sponsor)

Timeline

Jan 23, 2026 Raise Follow-on offering — Registered direct: $9M (total, as published), announced Jan 23, 2026. Source: company release on GlobeNewswire. source ↗
May 23, 2023 Trial start —: BVA-200 vs BVA-100 Validation Study source ↗
May 1, 2022 Trial start Not phased (device or behavioral study): Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure source ↗
Sep 16, 2021 Trial start —: Monitoring Outpatient Blood VolumE in Heart Failure source ↗
2009-01 Trial start —: Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer source ↗

Funding

Raised: $9.0M. Last 2 years.

Jan 23, 2026 Follow-on offering — Registered direct: $9M (total, as published), announced Jan 23, 2026. Source: company release on GlobeNewswire. source ↗

Clinical trials (lead sponsor) 4

Record	Title	Phase	Status	Start	Primary completion
NCT06227819	BVA-200 vs BVA-100 Validation Study	Not listed	Completed	May 23, 2023	Nov 30, 2023 (actual)
NCT04855097	Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure	Not phased (device or behavioral study)	Completed	May 1, 2022	Dec 31, 2022 (actual)
NCT04660396	Monitoring Outpatient Blood VolumE in Heart Failure	Not listed	Completed	Sep 16, 2021	Jul 15, 2022 (actual)
NCT01542749	Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer	Not listed	Completed	2009-01	2010-08 (actual)